Michael Peyton

14.0k citations

58 papers · 6.0k · 2 hit papers · h-index 35

Impact in

Sensory Systems top 0.2%
- Ion Channels and Receptors
Molecular Biology top 2%
- Ion channel regulation and function
- Cell death mechanisms and regulation
- RNA modifications and cancer

Papers in

Molecular Biology 38
- Genomics and Chromatin Dynamics 7
- PI3K/AKT/mTOR signaling in cancer 6
- Histone Deacetylase Inhibitors Research 4
- RNA modifications and cancer 4
Pulmonary and Respiratory Medicine 13
- Lung Cancer Treatments and Mutations 13

Co-authors: John D. Minna (41 shared papers)Lutz Birnbaumer (5 shared papers)Meisheng Jiang (4 shared papers)Luc Girard (24 shared papers)Guylain Boulay (3 shared papers)Adi F. Gazdar (16 shared papers)Xi Zhu (2 shared papers)Enrico Stefani (2 shared papers)
Journals: Cancer Research (13 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Thoracic Oncology (3 papers)PLoS ONE (3 papers)Oncogene (2 papers)
Partner nations: United States Japan Australia

In The Last Decade

Michael Peyton

56 papers receiving 5.9k citations

Michael Peyton's Hit Papers

align trajectories log scale

EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance 2013 · 437 citations

Peers

Countries citing papers authored by Michael Peyton

Since Specialization

Citations

This map shows the geographic impact of Michael Peyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Peyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Peyton more than expected).

Fields of papers citing papers by Michael Peyton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Peyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Peyton. The network helps show where Michael Peyton may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Peyton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Peyton Line = papers co-authored together Michael Peyton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	trp, a Novel Mammalian Gene Family Essential for Agonist-Activated Capacitative Ca2+ Entry Cell ·Xi Zhu, Meisheng Jiang, Michael Peyton, Guylain Boulay, Raymond S Hurst, Enrico Stefani, Lutz Birnbaumer Hit paper breakdown →	1996	618
2	Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis Cancer Cell ·Sean L. Petersen, Lai Wang, Asligul Yalcin-Chin, Lin Li, Michael Peyton, John D. Minna, Patrick G. Harran, Xiaodong Wang	2007	485
3	EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance Cell ·Yongjie Wei, Zhongju Zou, Nils Becker, Matthew Anderson, Rhea Sumpter, Guanghua Xiao, Lisa N. Kinch, Prasad Koduru, Christhunesa S. Christudass, Robert W. Veltri, Nick V. Grishin, Michael Peyton, John D. Minna, Govind Bhagat, Beth Levine Hit paper breakdown →	2013	437
4	Synthetic lethal screen identification of chemosensitizer loci in cancer cells Nature ·Angelique W. Whitehurst, Brian O. Bodemann, Jessica Cardenas, (unknown), Luc Girard, Michael Peyton, John D. Minna, Carolyn H. Michnoff, Wei-Hua Hao, Michael G. Roth, Xian‐Jin Xie, Michael A. White	2007	380
5	Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer Cancer Research ·Joseph M. Amann, Shailaja Kalyankrishna, Pierre P. Massion, Joyce E. Ohm, Luc Girard, Hisayuki Shigematsu, Michael Peyton, Denise M. Juroske, Yuhui Huang, J. Stuart Salmon, Young H. Kim, Jonathan R. Pollack, Kiyoshi Yanagisawa, Adi F. Gazdar, John D. Minna, Jonathan M. Kurie, David P. Carbone	2005	372
6	On the molecular basis and regulation of cellular capacitative calcium entry: Roles for Trp proteins Proceedings of the National Academy of Sciences ·Lutz Birnbaumer, Xiangcheng Zhu, Meisheng Jiang, Guylain Boulay, Michael Peyton, Brigitte Vannier, Darren L. Brown, Daniela Platano, M. Hamid, Enrico Stefani, Mariel Birnbaumer	1996	343
7	Molecular cloning of a widely expressed human homologue for the Drosophila trp gene FEBS Letters ·Xiangcheng Zhu, Phillip B. Chu, Michael Peyton, Lutz Birnbaumer	1995	314
8	Mouse trp2, the homologue of the human trpc2 pseudogene, encodes mTrp2, a store depletion-activated capacitative Ca ²⁺ entry channel Proceedings of the National Academy of Sciences ·Brigitte Vannier, Michael Peyton, Gulain Boulay, Darren L. Brown, Na Qin, Meisheng Jiang, Xi Zhu, Lutz Birnbaumer	1999	247
9	Multiple Oncogenic Changes (K-RASV12, p53 Knockdown,Mutant EGFRs, p16Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells Cancer Research ·Mitsuo Sato, Melville B. Vaughan, Luc Girard, Michael Peyton, Woochang Lee, David S. Shames, Ruben D. Ramirez, Noriaki Sunaga, Adi F. Gazdar, Jerry W. Shay, John D. Minna	2006	215
10	Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation Cancer Research ·Amit Kumar Das, Mitsuo Sato, Michael D. Story, Michael Peyton, Robert J. Graves, Stella Redpath, Luc Girard, Adi F. Gazdar, Jerry W. Shay, John D. Minna, Chaitanya S. Nirodi	2006	183
11	Multiple neurological abnormalities in mice deficient in the G protein G _o Proceedings of the National Academy of Sciences ·Meisheng Jiang, Michael S. Gold, Guylain Boulay, Karsten Spicher, Michael Peyton, Philippe Brabet, Yogambul Srinivasan, Uwe Rudolph, Gaylord Ellison, Lutz Birnbaumer	1998	182
12	Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines PLoS ONE ·Jeet Gandhi, Jianling Zhang, Yang Xie, Junichi Soh, Hisayuki Shigematsu, Wei Zhang, Hiromasa Yamamoto, Michael Peyton, Luc Girard, William W. Lockwood, Wan L. Lam, Marileila Varella‐Garcia, John D. Minna, Adi F. Gazdar	2009	174
13	MRI-Visible Micellar Nanomedicine for Targeted Drug Delivery to Lung Cancer Cells Molecular Pharmaceutics ·Jagadeesh Setti Guthi, Su-Geun Yang, Gang Huang, Shunzi Li, Chalermchai Khemtong, Chase W. Kessinger, Michael Peyton, John D. Minna, Kathlynn C. Brown, Jinming Gao	2009	163
14	Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis American Journal Of Pathology ·Elisa Benedettini, Lynette M. Sholl, Michael Peyton, John F. Reilly, Christopher Ware, Lenora J. Davis, Natalie Vena, D. R. Shackleton Bailey, Beow Y. Yeap, Michelangelo Fiorentino, Azra H. Ligon, Bo‐Sheng Pan, Victoria M. Richon, John D. Minna, Adi F. Gazdar, Giulio Draetta, Silvano Bòsari, Lucian R. Chirieac, Bart Lutterbach, Massimo Loda	2010	151
15	Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy Molecular Cancer Therapeutics ·Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori, John D. Minna	2011	138
16	Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo PLoS ONE ·Jieru Meng, Bingbing Dai, Bingliang Fang, B. Nebiyou Bekele, William G. Bornmann, Duoli Sun, Zhenghong Peng, Roy S. Herbst, Vassiliki A. Papadimitrakopoulou, John D. Minna, Michael Peyton, Jack A. Roth	2010	129
17	High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor Cancer Research ·Nobukazu Fujimoto, Marie Wislez, Jie Zhang, Kentaro Iwanaga, Jennifer Dackor, Amy E. Hanna, Shailaja Kalyankrishna, Dianna D. Cody, Roger E. Price, Mitsuo Sato, Jerry W. Shay, John D. Minna, Michael Peyton, Ximing Tang, Erminia Massarelli, Roy S. Herbst, David W. Threadgill, Ignacio I. Wistuba, Jonathan M. Kurie	2005	128
18	MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors International Journal of Cancer ·Takafumi Kubo, Hiromasa Yamamoto, William W. Lockwood, Ilse Valencia, Junichi Soh, Michael Peyton, Masaru Jida, Hiroki Otani, Tetsuya Fujii, Mamoru Ouchida, Nagio Takigawa, Katsuyuki Kiura, Kenji Shimizu, Hiroshi Date, John D. Minna, Marileila Varella‐Garcia, Wan L. Lam, Adi F. Gazdar, Shinichi Toyooka	2008	120
19	Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression Proceedings of the National Academy of Sciences ·Sean L. Petersen, Michael Peyton, John D. Minna, Xiaodong Wang	2010	100
20	Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. PubMed ·X. L. Xu, Leeju C. Wu, Feng Du, Alan R. Davis, Michael Peyton, Yoshio Tomizawa, A. Maitra, Gail E. Tomlinson, A F Gazdar, Bernard E. Weissman, A. Bowcock, Richard Baer, John D. Minna	2001	93

About Michael Peyton

Michael Peyton is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 58 papers that have together received 6.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Genomics and Chromatin Dynamics (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer Genomics and Diagnostics (4 papers), Histone Deacetylase Inhibitors Research (4 papers), RNA modifications and cancer (4 papers), interferon and immune responses (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Sensory Systems (1.1k citations), Molecular Biology (3.4k citations), Oncology (1.2k citations), Cancer Research (662 citations) and Cellular and Molecular Neuroscience (781 citations). Michael Peyton has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include John D. Minna, Lutz Birnbaumer, Meisheng Jiang, Luc Girard, Guylain Boulay, Adi F. Gazdar, Xi Zhu, Enrico Stefani, Xiangcheng Zhu and Xiaodong Wang. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Journal of Thoracic Oncology, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Michael Peyton

Impact in

Papers in i

In The Last Decade

Michael Peyton

Michael Peyton's Hit Papers

Peers

Countries citing papers authored by Michael Peyton

Fields of papers citing papers by Michael Peyton

All Works

About Michael Peyton

Explore authors with similar magnitude of impact

Papers in